パクリタキセル注射薬の調製時に発生した不溶物の生成原因と対策
スポンサーリンク
概要
- 論文の詳細を見る
The Pharmaceutical Department of Tokyo Teishin Hospital frequently encountered cases where insoluble matter formed during the preparation of paclitaxel injections. To deal with this situation, we discussed the mechanism of formation of the insoluble matter and countermeasures with the manufacturer of the drug product. Insoluble matter was observed with all paclitaxel injections examined, irrespective of the suppliers. Examination of the mechanism showed that frequent pushing-in- and- out (vertical) motions of the injection needle caused its silicone oil coating to be released and turn from white to black due to friction against the rubber stopper for the vial of the injection. The resulting matter then became inflated by the ethanol and polyoxyethylene castor oil in the injection liquid. Significant differences in the frequency of formation of insoluble matter were noted among the two manufacturers of injection needles compared, the lowest frequency being obtained from plastic injection needles. With this in mind, we selected a type of injection needle that is unlikely to produce insoluble matter, and minimized the number of vertical motions of the needle while preparing the injection. As a result, no insoluble matter formed in any of the 665 actually prepared vials. A trial assembly including an injection needle with a built-in filter also proved effective as a preventive measure against insoluble matter. In preparing an injectable drug, possible interactions with silicone oil that may be used in injection needles and syringes can lead to the formation of insoluble matter. Hence, special precautions should be exercised in the case of non-aqueous injections containing ethanol and/or polyoxyethylene castor oil.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)